Budesonide-formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial.

Noble JH, Bean O, Perry M, Sayers R, Cullen R, Black B, Holliday M, Eathorne A, Shortt N, Kirton L, Perry B, Bruce P, Leung W, Pavord ID, Weatherall M, Beasley RW, INFORM ASTHMA collaborators

Open source

DOI: 10.1016/s2213-2600(25)00327-3
Published: 2026 Feb
Container: The Lancet. Respiratory medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-25-00327-3,
  title = {Budesonide-formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial.},
  author = {Noble JH and Bean O and Perry M and Sayers R and Cullen R and Black B and Holliday M and Eathorne A and Shortt N and Kirton L and Perry B and Bruce P and Leung W and Pavord ID and Weatherall M and Beasley RW and INFORM ASTHMA collaborators},
  year = {2026},
  journal = {The Lancet. Respiratory medicine},
  doi = {10.1016/s2213-2600(25)00327-3},
  url = {https://doi.org/10.1016/s2213-2600(25)00327-3}
}

RIS

TY  - JOUR
TI  - Budesonide-formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial.
AU  - Noble JH
AU  - Bean O
AU  - Perry M
AU  - Sayers R
AU  - Cullen R
AU  - Black B
AU  - Holliday M
AU  - Eathorne A
AU  - Shortt N
AU  - Kirton L
AU  - Perry B
AU  - Bruce P
AU  - Leung W
AU  - Pavord ID
AU  - Weatherall M
AU  - Beasley RW
AU  - INFORM ASTHMA collaborators
PY  - 2026
JO  - The Lancet. Respiratory medicine
DO  - 10.1016/s2213-2600(25)00327-3
UR  - https://doi.org/10.1016/s2213-2600(25)00327-3
ER  -

APA

JH, N., O, B., M, P., R, S., R, C., B, B., M, H., A, E., N, S., L, K., B, P., P, B., W, L., ID, P., M, W., RW, B., & collaborators, I. A. (2026). Budesonide-formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial.. The Lancet. Respiratory medicine. https://doi.org/10.1016/s2213-2600(25)00327-3

Source records

pubmed · retrieved 2026-09-26T23:08:53.445Z